Synapse - Works

Results (5377)

Impact of novel therapies (NTs) on real-world (RW) clinical outcomes of patients (pts) with relapsed/refractory (RR) mantle-cell lymphoma (MCL) by race/ethnicity and TP53 mutation status

Meeting Abstract

Phillips, T. J.; Danilov, A. V.; Ruan, J.; Patel, K.; Kumar, A.; Wang, Y. C.; Maglinte, G. A.; Seymour, E.; Kamdar, M.
Blood (2024)

Fulltext@MSK | Save

Trials in progress: The START (STrategies for Anticoagulation in patients with thRombocytopenia and cancer-associated Thrombosis) pilot randomized controlled trial

Meeting Abstract

Wang, T. F.; Thomas, M.; Leader, A.; Cervi, A. L.; Wu, C. M.; Stanworth, S. J.; Carrier, M.
Blood (2024)

Fulltext@MSK | Save

Deep learning-driven 24-hour mortality risk assessment through peripheral blood smear morphology in hospitalized cancer patients

Meeting Abstract

Webb, D. C.; Colorado-Jimenez, C.; Fenelus, M.; Singi, S.; Yin, Z.; Paulsen, S.; Bilal, K. H.; Herskovitz, A. Z.; McCash, S.; Wang, L.; more...
Blood (2024)

Fulltext@MSK | Save

An open-label, multi-center phase 2 study to assess the safety and efficacy of burixafor (GPC-100) and propranolol with G-CSF for the mobilization of stem cells in patients with multiple myeloma undergoing autologous stem cell transplant

Meeting Abstract

Caculitan, N.; Kim, G.; Woolfrey, A.; Akard, L. P.; Jeong, A. R.; Khouri, J.; Shah, G. L.; Cardarelli, P. M.
Blood (2024)

Fulltext@MSK | Save

Risk factors associated with sub-optimal outcomes following obecabtagene autoleucel (obe-cel) for relapsed/refractory B-cell acute lymphoblastic leukemia (R/R B-ALL): What we have learned from the FELIX trial

Meeting Abstract

Roddie, C.; Park, J. H.; Shaughnessy, P.; Logan, A. C.; Sandhu, K. S.; Abedi, M.; Shah, B. D.; Bishop, M. R.; DeAngelo, D. J.; Brugger, W.; more...
Blood (2024)

Fulltext@MSK | Save

Advancing patient-centered care to overcome health disparities in multiple myeloma: key findings from a quality improvement initiative

Meeting Abstract

Mikhael, J.; Rodriguez, C.; Pierre, A. E.; Nawaz, M. S.; Moses-Okwei, E.; Gurska, L.; Zyborowicz, E.; Sullivan, S.; Carter, J.; Heggen, C.
Blood (2024)

Fulltext@MSK | Save

Manufacture of anti-BCMA CAR T cell is feasible after salvage autologous or allogeneic hematopoietic stem cell transplantation

Meeting Abstract

Shah, G. L.; Perica, K.; Nagel, K.; Payson, E.; Hosszu, K. K.; Chung, D. J.; Landau, H. J.; Scordo, M.; Hultcrantz, M.; Korde, N.; more...
Blood (2024)

Fulltext@MSK | Save

Safety and efficacy of belantamab mafadotin in patients with relapsed/refractory multiple myeloma: A real-world experience

Meeting Abstract

Dileo, R.; Mewawalla, P.; Patrus, G.; Strouse, C.; Chen, E.; Shaikh, H.; Davis, J. A.; Green, K. M.; Alkharabsheh, O.; Rashid, A.; more...
Blood (2024)

Fulltext@MSK | Save

Mitochondrial augmentation of hematopoietic stem and progenitor cells as a new therapeutic approach for myelodysplasia

Meeting Abstract

Fujino, T.; Avni, N.; Kutner, N.; Khoury, H.; Pozner, G.; Sabath, N.; Castro, C.; Fox, N.; Lewis, A. M.; Tittley, S.; more...
Blood (2024)

Fulltext@MSK | Save

Delayed neurotoxicity after CAR-T in multiple myeloma: Results from a global IMWG registry

Meeting Abstract

Kumar, A. D.; Atallah-Yunes, S. A.; Rajeeve, S.; Abdelhak, A.; Hashmi, H.; Corraes, A.; Htut, M.; Rodriguez-Otero, P.; Parrondo, R. D.; Chhabra, S.; more...
Blood (2024)

Fulltext@MSK | Save